Profile of Paul Wyatt
Paul is currently Head of The Drug Discovery Unit. His current role is to develop translational research at Dundee, by bringing together his and other’s experience of Drug Discovery in the Pharma/Biotech sector with basic academic research to de-risk novel targets for drug discovery and new treatments for diseases such as TB and cancer.
Previously Paul worked within the BioPharma industry (GSK, Astex Therapeutics) for 23 years, gaining experience across a range of therapeutic areas. He played a significant part in seven compounds entering pre-clinical development, two of which are now in Phase II clinical trials. Paul obtained his BSc and PhD in Chemistry from the University of Birmingham. Paul has published around 50 papers and he is an inventor on over 35 patent applications.